Abstract
The most common indication for an endomyocardial biopsy (EMB) is surveillance for post–heart transplant cellular rejection. Another frequent indication is in idiopathic cardiomyopathies, as a guide for therapy (myocarditis vs. cardiomyopathy) or for prognostic purposes (cardiomyopathy, glycogen storage disease, metabolic disorders).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hauptman PJ, Gass A, Cohen M et al. Endomyocardial biopsy: advantages of adding a posterior bend to the bioptome. Cathet Cardiovasc Diagn 1992;27: 228–229.
Pophal SG, Sigfusson G, Booth KL et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999;34(7):2105–2110.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bergersen, L., Foerster, S., Marshall, A.C., Meadows, J. (2009). Endomyocardial Biopsy. In: Bergersen, L., Foerster, S., Marshall, A.C., Meadows, J. (eds) Congenital Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-77292-9_22
Download citation
DOI: https://doi.org/10.1007/978-0-387-77292-9_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-77291-2
Online ISBN: 978-0-387-77292-9
eBook Packages: MedicineMedicine (R0)